Pausing wilson disease drugs for better monitoring?
NCT ID NCT07301216
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether briefly stopping Wilson disease medication can give a clearer picture of copper levels in the body. Researchers will monitor 30 stable patients for 4 days off treatment, measuring urine copper and blood markers. The goal is to find a better way to track disease stability without relying on long-term treatment changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a simpler, more reliable way to monitor Wilson disease stability without needing frequent blood tests.
- What could go wrong
- This is a small, early study with only 30 people. Stopping medication temporarily carries risks of copper buildup, and the findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- Can a One-Time gene fix cure wilson disease?
- Can a single infusion rewrite the genetic code behind wilson disease?
- Newborn screening study aims to catch rare diseases at birth
- Building a database to unlock wilson disease mysteries
- New Free-Breathing MRI could make liver scans easier for kids